October 14, 2010 – An injectable magnetic resonance angiography (MRA) blood pool imaging agent has been released in Canada. Ablavar, which is made by Lantheus Medical Imaging and previously marketed as Vasovist, is indicated for contrast-enhanced MRA for visualization of abdominal or limb vessels in patients with suspected or known vascular disease.

October 14, 2010 – A new round of equity financing will help launch the LipiScan IVUS Coronary Imaging System in the United States. InfraReDx raised $21 million to launch the first system to combine intravascular ultrasound (IVUS) with the company’s near infrared (NIR) spectroscopy.

October 14, 2010 – A bifurcation stent maker has closed $17 million in round D financing to help it expand worldwide, pursue research and development and seek out regulatory approvals in the United States, Japan and China. TriReme Medical announced the funding, which was led by Bio*One Capital.

October 14, 2010 – A new echocardiography management program has been launched with Blue Cross and Blue Shield of Vermont (BCBCVT). American Imaging Management (AIM) will partner with BCBSVT to support more consistent use of those services.

AMI has provided diagnostic imaging clinical review services for Vermont health plans since 2008.

October 13, 2010 – A new guidewire has been launched for use in challenging, small vessel peripheral angioplasty procedures. The Journey Guidewire, by Boston Scientific, is 0.014 inches and designed to address physician needs in treating arteries below the knee.

October 13, 2010 – A cardiac workstation software upgrade has been released that enables healthcare professionals to digitally store and review diagnostic test data. Version 1.6.3 of Welch Allyn’s CardioPerfect Workstation maximizes workflow efficiency and simplifies electronic health record (EHR) integration in ambulatory care settings that utilize thin-client technology.

October 13, 2010 – A recall was issued for bottles of 40 mg Lipitor, due to a small number of reports of an uncharacteristic odor related to the packaging.

A medical assessment has determined that the odor is not likely to cause adverse health effects. However, Pfizer recommends that anyone taking 40 mg Lipitor who experiences a strange odor should return the tablets to their pharmacist.

October 13, 2010 – The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it had cardiovascular safety risks. Sibutramine (Meridia), made by Abbott, is a prescription medicine used to help overweight or obese people lose weight.

Abbott is voluntarily withdrawing the drug at the request of the U.S. Food and Drug Administration (FDA).

October 13, 2010 – Human trials commenced using a catheter guidance control and imaging (CGCI) system on patients with arrhythmias.

The Floor Post series of radiology workstations is designed to make the most of limited space by accommodating multiple simultaneous users.

It has a single column with a secure track on two sides for mounting monitors, keyboards and CPUs. The design allows for flexible configuration, with the option to create up to four workstations on one post. It can become a highly functional technology hub in almost any medical facility location, including crowded treatment rooms and hallways.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now